Published in Ann Neurol on November 01, 1999
Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry (2005) 4.86
Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res (2008) 2.02
Antiepileptic drug use by pregnant women enrolled in Florida Medicaid. Neurology (2015) 1.41
Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed (2005) 1.17
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol (2007) 1.13
Use of antiepileptic medications in pregnancy in relation to risks of birth defects. Ann Epidemiol (2011) 1.08
Teratogenic effects of antiepileptic drugs. Expert Rev Neurother (2010) 1.05
Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest? Epilepsia (2008) 1.04
Methylxanthines, seizures, and excitotoxicity. Handb Exp Pharmacol (2011) 0.99
Antiepileptic drug use in women of childbearing age. Epilepsy Behav (2009) 0.99
Medical genetics: 1. Clinical teratology in the age of genomics. CMAJ (2002) 0.98
Epilepsy in pregnancy. BMJ (2007) 0.97
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2016) 0.96
Using current evidence in selecting antiepileptic drugs for use during pregnancy. Epilepsy Curr (2005) 0.95
Antiepileptic drugs and pregnancy outcomes. Am J Med Genet A (2012) 0.92
Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research. Epilepsy Behav (2013) 0.90
Is carbamazepine safe to take during pregnancy? Can Fam Physician (2012) 0.90
Epilepsy drugs and effects on fetal development: Potential mechanisms. J Res Med Sci (2012) 0.85
Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiol Drug Saf (2012) 0.84
Major malformations with valproic acid. Can Fam Physician (2006) 0.83
Pregnancy and epilepsy: what should we tell our patients? J Neurol (2009) 0.79
Maternal caffeine consumption and risk of congenital limb deficiencies. Birth Defects Res A Clin Mol Teratol (2012) 0.78
Prenatal exposure to carbamazepine reduces hippocampal and cortical neuronal cell population in new-born and young mice without detectable effects on learning and memory. PLoS One (2013) 0.78
Pregnancy, epilepsy, and anticonvulsants. Dialogues Clin Neurosci (2008) 0.78
Management of epilepsy in women. Postgrad Med J (2005) 0.77
NICE guidance on newer drugs for epilepsy in adults. BMJ (2004) 0.77
Drug selection for the newly diagnosed patient: when is a new generation antiepileptic drug indicated? J Neurol (2004) 0.77
Effect of anti-epileptic drugs in pregnancy and teratogenesis. Indian J Clin Biochem (2008) 0.77
Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine. Neurotoxicol Teratol (2016) 0.76
Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy? Obstet Med (2012) 0.75
Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy Registry. Pharmacoepidemiol Drug Saf (2014) 0.75
Too Complicated or So Simple: AED Type and AED Dose Matter for Pregnancy. Epilepsy Curr (2012) 0.75
Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges. Drug Healthc Patient Saf (2014) 0.75
Women and epilepsy. J Pediatr Pharmacol Ther (2009) 0.75
Obstetric and birth outcomes in pregnant women with epilepsy: A hospital-based study. Ann Indian Acad Neurol (2013) 0.75
Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model. BMC Pregnancy Childbirth (2017) 0.75
Epilepsy during pregnancy: focus on management strategies. Int J Womens Health (2016) 0.75
The Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature Review. Drugs Real World Outcomes (2016) 0.75
Should valproate be taken during pregnancy? Ther Clin Risk Manag (2005) 0.75
Unilateral multicystic dysplastic kidney in infants exposed to antiepileptic drugs during pregnancy. Pediatr Nephrol (2007) 0.75
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology (1999) 7.55
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science (1997) 6.10
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell (1996) 5.99
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med (1995) 5.12
The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology (1995) 5.08
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med (2000) 5.02
Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol (1998) 4.91
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99
J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet (1994) 3.95
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology (2008) 3.76
J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension (1999) 3.51
Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology (2012) 3.47
Confounding by indication: an example of variation in the use of epidemiologic terminology. Am J Epidemiol (1999) 3.44
Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. BMJ (1995) 3.42
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol (1998) 3.37
The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology (1994) 3.30
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet (1998) 3.26
Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study. Invest Ophthalmol Vis Sci (2000) 3.19
Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J (1999) 3.18
The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J (2001) 3.07
Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol (1996) 2.80
Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam Scan Study. Neurology (2001) 2.80
Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke (1997) 2.79
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet (1998) 2.73
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2008) 2.72
Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann Intern Med (1995) 2.70
Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67
Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia (2003) 2.66
Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet (1994) 2.65
Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med (1998) 2.64
Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.63
Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study. Ann Rheum Dis (2011) 2.61
Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ (1994) 2.60
C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation (2005) 2.59
A comparison of body mass index, waist-hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab Disord (2001) 2.55
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol (1998) 2.53
Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study. Stroke (2001) 2.49
Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology (1995) 2.43
NSAIDs and incident Alzheimer's disease. The Rotterdam Study. Neurobiol Aging (1999) 2.41
Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet (1992) 2.40
Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage (2010) 2.39
Decreased selenium levels in acute myocardial infarction. JAMA (1989) 2.36
Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.36
Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology (2004) 2.35
Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet (1999) 2.32
A randomized trial of sodium intake and blood pressure in newborn infants. JAMA (1983) 2.32
Hypertension and cerebral white matter lesions in a prospective cohort study. Brain (2002) 2.31
Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol (1998) 2.31
Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke (2003) 2.31
Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology (1995) 2.30
Genome-wide association scan for five major dimensions of personality. Mol Psychiatry (2008) 2.29
Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet (1998) 2.26
Carotid intima-media thickness at different sites: relation to incident myocardial infarction; The Rotterdam Study. Eur Heart J (2002) 2.22
Costs and effects of long-term oral anticoagulant treatment after myocardial infarction. JAMA (1995) 2.20
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2006) 2.19
Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry (2003) 2.18
Diet and risk of dementia: Does fat matter?: The Rotterdam Study. Neurology (2002) 2.16
QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation (1998) 2.15
Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int (2005) 2.15
Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke (1994) 2.14
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Postprandial triglyceride response in young adult men and familial risk for coronary atherosclerosis. Ann Intern Med (1994) 2.11
Determinants of optic disc characteristics in a general population: The Rotterdam Study. Ophthalmology (1999) 2.09
Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch Intern Med (1999) 2.09
Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. Eur Heart J (1999) 2.09
Associations of radiological osteoarthritis of the hip and knee with locomotor disability in the Rotterdam Study. Ann Rheum Dis (1998) 2.08
Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci (2001) 2.04
Distribution of central corneal thickness and its association with intraocular pressure: The Rotterdam Study. Am J Ophthalmol (1997) 2.04